Keywords: gsk, licenses, second, flap, inhibitor, amira, under

GSK licenses second FLAP inhibitor from Amira

Article | 09 June 2008

Print This

Under the terms of their worldwide exclusive agreement, UK drug major GlaxoSmithKline intends to exercise its right to a second ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in